Weiming Chen

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 7

Top Topics

Molecular Docking

Oxide Nanoparticles

Molecularly Imprinted

Top Venues

Organic letters

This page only lists publications with an associated author ORCID identifier.

Publications

Weiming Chen, Jiatao Xia, Jiuzhong Huang, Lianlian Zhou, Gaorong Wu
Chemoselective C-H Hydroxylation and Borylation of N -Phenylbenzamides using BBr 3 . Organic letters 26 (22) (2024)
Weiming Chen, Jiatao Xia, Jiuzhong Huang, Lianlian Zhou, Gaorong Wu
Chemoselective C-H Hydroxylation and Borylation of N -Phenylbenzamides using BBr 3 . Organic letters (2024)
Wei Hu, Yuanchang Liu, Xiang Zhang, Panpan Zheng, Feifei Yang, Guangyang Guo, Xin Xie, Jiuzhong Huang, Weiming Chen
Small change for big improvement in the preparation of the key intermediate N 1 , N 3 -disubstituted 1,3,5-triazone of ensitrelvir. RSC advances 13 (6) (2023)
Wei Hu, Yuanchang Liu, Xiang Zhang, Panpan Zheng, Feifei Yang, Guangyang Guo, Xin Xie, Jiuzhong Huang, Weiming Chen
Small change for big improvement in the preparation of the key intermediate N 1 , N 3 -disubstituted 1,3,5-triazone of ensitrelvir. RSC advances 13 (6) (2023)
Wei Hu, Xiang Zhang, Yuanchang Liu, Teng Liu, Jiale Wen, Xiaopeng Peng, Xin Xie, Weiming Chen
Two-stage one-pot synthetic strategy for the key triazone-triazole intermediate of ensitrelvir (S-217622), an oral clinical candidate for treating COVID-19. RSC advances 12 (54) (2022)
Xiaoning Li, Zunsheng Chen, Weiming Chen, Xin Xie, Hui Zhou, Yingmei Liao, Fu-Chao Yu, Jiuzhong Huang
B<sub>2</sub>pin<sub>2</sub>-Mediated Cascade Cyclization/Aromatization Reaction: Facial Access to Functionalized Indolizines. Organic letters 24 (40) (2022)
Wei Hu, Xiang Zhang, Yuanchang Liu, Teng Liu, Jiale Wen, Xiaopeng Peng, Xin Xie, Weiming Chen
Two-stage one-pot synthetic strategy for the key triazone-triazole intermediate of ensitrelvir (S-217622), an oral clinical candidate for treating COVID-19. RSC advances 12 (54) (2022)